CENSIS is working with the Digital Health Validation Lab (DHVL) to develop a support network for digital health innovators.
The network will be particularly focused on the regulatory environments of products, and aims to address areas of particular challenge within the digital health landscape.
By creating a network that develops regulatory science approaches that span the entire product development cycle, DHVL aims to help innovators deliver high-impact digital health products and services that can be scaled up to benefit the UK and worldwide healthcare systems.
A key feature of the network will be DHVL’s ability to generate real world clinical evidence to support regulatory submissions. This is a rapidly increasing element of the digital health market, and is critical in assuring the safety, effectiveness, and compliance of digital health technologies such as apps, medical devices, and software solutions.
Businesses and innovators involved in – or thinking about becoming involved in – the delivery of digital healthcare are invited to take a survey to help DHVL understand regulatory needs and determine the network’s priorities.
Along with CENSIS, other partners working with DHVL on this initiative include Canon Medical Research Europe, STAC (Smart Things Accelerator Centre), NHS Greater Glasgow and Clyde, and InnoScot Health.
This development work is funded by Innovate UK as part of its UK Regulatory Science and Innovation Networks programme – a key initiative for harnessing the power of regulatory science to generate evidence and intelligence which informs regulatory policy and practice.
The Digital Health Validation Lab (DHVL) is enabled by the UKRI-funded Living Laboratory programme, established to drive the co-development of healthcare innovations and their adoption into clinical settings through generation of real world evidence.